The history of Viagra and its impact on the pharmaceutical sector presents a complex question regarding its continued appeal as an investment. Initially a remarkable success, generating billions , generic competition has substantially eroded earnings . While major pharmaceutical firms continue patents on related therapies and develop new formulatio

The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key markets has introduced significant risk . Investors are now assessing the impact of rival medications , sh